Twist Bioscience faces federal securities lawsuit over accounting fraud, inflated financials.

Kuehn Law is investigating Twist Bioscience Corporation for potential breaches of fiduciary duties by its officers and directors. The lawsuit claims that insiders made misleading statements and failed to disclose material facts about the company's business and operations. Specifically, the complaint alleges that insiders overstated the commercial viability of Twist's synthetic DNA manufacturing technology and engaged in accounting fraud. If you own TWST and purchased prior to December 13, 2019, you may be eligible for compensation.